FMCSA Clearinghouse effective date is January 6, 2020
After several months of buildup, the transportation industry has reached the Federal Motor Carrier Safety Administration (FMCSA) Clearinghouse effective date of January 6, 2020.
After several months of buildup, the transportation industry has reached the Federal Motor Carrier Safety Administration (FMCSA) Clearinghouse effective date of January 6, 2020.
Employers and owner-operators can take advantage of the current open enrollment for DOT consortium period to help them remain compliant with Federal Motor Carrier Safety Administration (FMCSA) regulations.
Employers and owner-operators who participate in a consortium can take the guesswork out of DOT random drug testing rules by virtue of the larger group size and expertise of a certified third-party administrator (C-TPA).
DOT regulations that pertain to truck driver drug testing as a condition of employment with a new employer will not change.
DOT regulations that pertain to CDL holders and applicants are different from those mandated by the new CDL Drug and Alcohol Clearinghouse.
Green Bay, Wisconsin-based Wisconsin Drug Testing Consortium has received official recognition from the Drug & Alcohol Testing Industry Association (DATIA) as being Nationally Accredited for Administration of Drug and Alcohol Testing Programs (NAADATP).
Most employers know that CDL drivers must pass a DOT pre-employment drug test prior to performing any safety-sensitive function, but this requirement is just one of the basic requirements needed to qualify an applicant for driving with a CDL license.
The Federal Motor Carrier Safety Administration (FMCSA) continues to update its resources pertaining to DOT guidelines for the drug testing Clearinghouse.
The CDL Drug and Alcohol Clearinghouse will support the DOT Strategic Goal of Safety when it goes live on January 4, 2020, by ensuring drivers are qualified to operate trucks and buses.
Wisconsin Drug Testing Consortium (WDTC) manages the random DOT testing programs for multiple employers and owner-operators in its role as one of northeast Wisconsin’s trusted drug testing consortiums.